Comments to FDA: OTC Drug Monograph System Share page: Docket Number: FDA-2014-N-0202 CHPA applauds and is strongly supportive of FDA's re-examination of the monograph system in an effort to complete the OTC Drug Review. Download Document Issues: OTC Medicines Monograph Reform Related Posts Comments Comments Regarding Provisions Pertaining to Preventing Access to U.S. Sensitive Personal Data and Government-Related Data Nov 28, 2024 Press Releases and Statements CHPA Responds to Nomination of Dr. Marty Makary for FDA Commissioner Nov 25, 2024 Polibrief Per-and Polyfluoroalkyl Substances (PFAS) Nov 20, 2024